Skin Dose from Radioactive Contamination

When a radionuclide lands on skin, the dose that matters is one a personnel badge never records: the shallow-dose equivalent to the skin's sensitive basal layer at a depth of 7 mg/cm², averaged over the 10 cm² receiving the highest exposure. It is dominated by beta particles and low-energy photons that stop in the first fraction of a millimeter of tissue, and it accrues for exactly as long as the contamination stays put — which is why prompt survey and decontamination, not shielding, are the controls that count. ^{1, 2, 4}

Introduction

Radiation safety programs are built around the whole-body dosimeter clipped to the trunk. That dosimeter reports deep-dose equivalent — the dose to organs at 1 cm depth — and it is the right instrument for penetrating gamma fields. But it is nearly blind to a very common event in a nuclear medicine department or research lab: a drop of a radiopharmaceutical, a splash of eluate, or a smear of activity on a glove that reaches bare skin. The energy from that contamination is deposited in the outermost layers of tissue and never travels the centimeter needed to register as deep dose. ^{1, 3}

Skin dose is therefore a distinct quantity with its own definition, its own limit, its own measurement tools, and its own response. It is governed by the shallow-dose equivalent — the dose at 0.007 cm (7 mg/cm²), the depth of the radiosensitive basal cells — and its annual occupational limit is 50 rem (500 mSv), ten times the whole-body effective-dose limit, reflecting the skin's greater radioresistance. ^{1, 2} That higher limit is not permission to be casual: an unaddressed spill on skin can accrue a meaningful shallow-dose equivalent quickly, and every such event has to be assessed, decontaminated, and documented.

This guide explains how skin dose from contamination is defined and calculated, which radionuclides drive it, the VARSKIN-class tools used to assess it, the regulatory limit and averaging rules, and the practical program — survey, decontaminate, assess, document — that keeps a routine spill from becoming a recordable dose. DRPS provides this radiation safety support across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware as part of its radiation safety officer and radiation safety training services.

Topic Explanation

What "skin dose" actually means

Skin dose from contamination is the shallow-dose equivalent delivered to the basal layer of the epidermis by a radionuclide deposited on the skin or on clothing in contact with the skin. Three regulatory definitions pin it down:

The assessment depth is 7 mg/cm² (0.007 cm), the nominal depth of the basal cells that regenerate the skin and are the relevant target for deterministic and stochastic skin effects. ²
The dose is averaged over the 10 cm² of skin receiving the highest exposure. The NRC amended this averaging area from 1 cm² to 10 cm² in 2002, making the assessment less punitive for a small, concentrated deposit. ³
The quantity is the shallow-dose equivalent (SDE), the external dose to the skin or an extremity at that 7 mg/cm² depth. ²

Because the target is so shallow, skin dose is dominated by short-range radiation — beta particles and low-energy photons and conversion electrons — that deposits its energy before reaching deeper tissue. A high-energy gamma emitter contributes relatively little skin dose per unit surface activity (its energy mostly passes through), while a high-energy beta emitter contributes a great deal. ^{2, 4}

Why the whole-body badge misses it

A deep-dose dosimeter is designed and calibrated to report dose at 1 cm depth and is worn on the trunk. Contamination on a finger, a forearm, or a lab-coat sleeve is often nowhere near the badge, and even when it is close, the beta energy that drives skin dose cannot penetrate to the badge's deep-dose element. Programs that handle unsealed radionuclides therefore add extremity dosimetry (ring badges) for the hands and rely on contamination surveys to catch skin deposits the badges cannot. Our guide to extremity dosimetry in nuclear medicine covers the ring-badge side; this article focuses on the surface-contamination side. ¹

Key Technical Principles

The dose equation is rate times time

Skin dose from a fixed surface contamination is deceptively simple in structure:

SDE = \dot{D}_{skin} \times t

where $\dot{D}_{skin}$ is the shallow-dose-equivalent rate produced by the contamination and $t$ is the contact time. The entire operational message of skin-dose control lives in that equation: for a given contamination, dose is proportional to how long it stays on the skin. Halving the contact time halves the dose. ^{2, 4}

The rate $\dot{D}_{skin}$ depends on the radionuclide's emissions, the surface activity concentration (activity per unit area), and any cover material or air gap between the source and the skin. Computing it by hand for a real beta spectrum is impractical, which is why the standard of practice is a dedicated code.

VARSKIN: the assessment tool

VARSKIN is the NRC-sponsored computer code for skin-contamination dosimetry, and it is the accepted method for assessing a skin-contamination event. The current version, VARSKIN+, is documented in NUREG/CR-6918, Revision 4 (2021), and computes the shallow-dose equivalent from a specified radionuclide, activity, source geometry and area, cover/air-gap conditions, and exposure time, using ICRP nuclear decay data (ICRP Publication 107). Its default dose-averaging area is 10 cm², matching the regulatory averaging rule, and it handles both the beta/electron and photon contributions. ⁴

For an order-of-magnitude sense of scale, a high-energy beta emitter such as phosphorus-32 (beta Emax ≈ 1.71 MeV) produces, by VARSKIN-class calculation, a shallow-dose-equivalent rate on the order of tens of mGy per hour per µCi/cm² of skin contamination at 7 mg/cm² — a useful reminder that even sub-microcurie deposits are worth removing promptly, and that the exact value must be computed for the specific radionuclide, activity, and geometry rather than assumed. ^{2, 4}

A worked skin-dose example

Suppose a technologist's forearm is contaminated with phosphorus-32 at a surface concentration of 0.5 µCi/cm², and — for illustration — a VARSKIN calculation for that nuclide and geometry returns a shallow-dose-equivalent rate of

\dot{D}_{skin} \approx 45 mGy/h (\approx 45 mSv/h for beta/electron skin dose)

If the contamination is detected and decontaminated after 20 minutes ( $t = 0.33$ h), the accrued shallow-dose equivalent is

SDE = 45 mSv/h \times 0.33 h \approx 15 mSv

which is about

\frac{15 mSv}{500 mSv} \times 100% \approx 3%

of the annual 50 rem (500 mSv) skin limit. Had the same contamination gone unnoticed on a covered forearm for a full 8-hour shift, the dose would have approached the annual limit. The time it takes to reach the limit at that rate is

t_{limit} = \frac{500 mSv}{45 mSv/h} \approx 11 h

The numbers are illustrative — the dose rate must be computed for the actual nuclide, activity, and cover conditions — but the lesson is exact: detection and decontamination time is the dominant variable, and a prompt response keeps a spill in the low-percent range of the limit rather than near it. ^{1, 2, 4}

Radionuclide dependence

The skin-dose consequence of a given contamination depends heavily on the radionuclide's emissions. Higher beta endpoint energies penetrate to and beyond the 7 mg/cm² basal layer, delivering more dose; very low-energy or purely photon emitters deliver less.

Radionuclide	Principal skin-relevant emission	Beta/positron Emax	Relative skin-dose concern	Note
Y-90	Beta⁻	~2.28 MeV	Very high	Used in radioembolization and radiopharmaceutical therapy
P-32	Beta⁻	~1.71 MeV	Very high	Classic high-skin-dose research/therapy nuclide
Ga-68	Beta⁺	~1.9 MeV	High but brief	Very short half-life limits integrated dose
F-18	Beta⁺	~0.63 MeV	Moderate, brief	110-min half-life; decays quickly
I-131	Beta⁻ (+ gamma)	~0.61 MeV	Moderate	Volatility and gamma add other pathways
Lu-177	Beta⁻ (+ gamma)	~0.50 MeV	Moderate	Common in radiopharmaceutical therapy
Tc-99m	Gamma (+ conversion electrons)	No primary beta	Low	Low-energy photons; limited skin dose

Beta endpoint energies are nuclide-specific decay data and are used here to rank relative concern; the actual dose for any event must be computed for the specific activity, area, and cover. ^{2, 9}

Clinical Impact

Skin contamination is one of the most frequent radiation safety events in a nuclear medicine department, and its dose consequence is almost entirely determined by how the program responds. Radiopharmaceutical preparation, dose drawing, generator elution, injection, and patient care all create opportunities for surface contamination on gloves, skin, and clothing. In the overwhelming majority of cases, prompt detection and decontamination keep the shallow-dose equivalent trivially small. The failures that produce a meaningful dose share a pattern: contamination that is not detected (no survey, or an instrument unsuited to the emission), contamination under a glove or sleeve where it is out of sight, or a delayed response. ^{1, 2}

The clinical stakes are twofold. First, a high-energy beta emitter left on skin can, in principle, produce a localized deterministic skin injury if the activity is high and the dwell time long — the reason "hot particle" and concentrated-deposit scenarios receive special attention. Second, even short of injury, an assessed skin dose becomes part of the worker's dose of record and can, in a serious event, approach or exceed regulatory limits, triggering investigation and reporting. A disciplined survey-and-decontaminate culture is what keeps skin contamination in the "minor, documented, resolved" category. For the survey and decontamination practices that support this, see nuclear medicine decontamination best practices and radioactive material spill response. ¹

Practical Optimization Tips

Detect fast and correctly

Survey hands and clothing routinely after handling unsealed radionuclides, using an instrument matched to the emission — a thin-window (pancake) GM detector for beta contamination, appropriate probes for low-energy photons. Choosing the right instrument is itself a skill; see choosing the right radiation survey meter.
Do not rely on the whole-body badge to reveal skin contamination — it will not.
Set and use contamination action levels so a positive survey triggers a defined response, not a judgment call.

Decontaminate promptly and gently

Begin decontamination as soon as contamination is confirmed — time is the dominant dose variable.
Work from the outside of the contaminated area inward with lukewarm water and mild soap; avoid hot water, harsh scrubbing, and abrasion, which can open the skin barrier and drive activity into tissue.
Resurvey after each attempt and stop when levels reach the action level or removal plateaus; escalate persistent contamination to the RSO.

Assess the dose defensibly

Use VARSKIN (or an equivalent accepted method) to assess the shallow-dose equivalent for any significant skin contamination, recording the radionuclide, activity, area, cover conditions, and estimated contact time. ⁴
Apply the 10 cm² averaging area and the 7 mg/cm² depth consistently with the regulations. ^{2, 3}
Document the event and the dose of record, and feed the result into the individual's occupational dose per Regulatory Guide 8.34. ⁵

Prevent the next event

Engineer the workflow: absorbent bench coverings, appropriate gloves (double-gloving for high-activity handling), shielding of syringes and vials, and controlled work areas.
Investigate every contamination event for the process gap that allowed it, and adjust technique or training accordingly.

Common pitfalls to avoid

Assuming the personnel badge captures skin dose. It does not; skin dose needs surveys and, when contamination occurs, a VARSKIN-class assessment.
Treating a high skin-dose limit as low risk. The 500 mSv limit is generous, but concentrated high-energy beta contamination can still approach it if left in place.
Aggressive decontamination. Scrubbing to the point of breaking skin converts a surface problem into a wound-contamination and internal-dose problem.
Skipping documentation. An unassessed, undocumented skin contamination is a compliance gap even when the actual dose was small.

Regulatory Considerations

Skin contamination involves radioactive material, so it falls under NRC or Agreement State regulation of byproduct material, and the shallow-dose equivalent is the governed quantity. The key frameworks:

10 CFR 20.1201 — Occupational dose limits for adults sets the annual shallow-dose-equivalent limit at 50 rem (500 mSv) to the skin of the whole body or to the skin of any extremity, and specifies that the assigned SDE is the dose averaged over the 10 cm² of skin receiving the highest exposure. ^{1, 3}
10 CFR 20.1003 — Definitions establishes the shallow-dose equivalent and the 0.007 cm (7 mg/cm²) assessment depth. ²
10 CFR 20.1501 — Surveys and monitoring requires surveys adequate to evaluate the magnitude and extent of radiation levels and contamination, which is the regulatory hook for the routine and event-driven surveys that detect skin contamination. ⁶
NRC Regulatory Guide 8.34, Revision 1 (2022) describes acceptable methods for monitoring and calculating occupational doses, including skin and extremity contributions, and reflects the current expectations for dose-of-record calculations. ⁵
NUREG/CR-6918 (VARSKIN) is the NRC-sponsored basis for skin-dose assessment from contamination. ⁴
ICRP Publication 103 provides the radiation-protection framework — including the treatment of skin as a tissue with its own dose considerations — that underlies these limits. ⁷

Jurisdiction matters. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that administer their own equivalent radiation-control rules for byproduct material, while Washington DC and Delaware are regulated directly by the NRC. The skin-dose limits and averaging rules are equivalent, but the licensing authority, survey expectations, and reporting thresholds are administered by the authority having jurisdiction, which a facility must confirm. Contamination detected during package receipt has its own monitoring requirements under 10 CFR 20.1906, discussed in our guide to package receipt and wipe testing. ^{1, 5, 10}

Frequently Asked Questions (FAQs)

What is skin dose from contamination, and why is it measured separately?

Skin dose is the radiation dose delivered to the radiosensitive basal layer of the skin when a radionuclide is deposited on the skin or on clothing. It is quantified as the shallow-dose equivalent at a tissue depth of 0.007 cm (7 mg/cm²), averaged over the 10 cm² of skin receiving the highest exposure. It is assessed separately because it is driven by beta particles and low-energy photons that a whole-body deep-dose dosimeter, worn on the trunk, does not capture.

What is the regulatory limit for skin dose?

Under 10 CFR 20.1201, the annual occupational limit on the shallow-dose equivalent is 50 rem (0.5 Sv, 500 mSv) to the skin of the whole body or to the skin of any extremity. This is far higher than the 5 rem (50 mSv) annual total effective dose equivalent limit because the skin is more radioresistant than deep organs, but the shallow-dose limit still governs contamination events and must be assessed and recorded when contamination occurs.

How is skin dose from contamination calculated?

The standard tool is VARSKIN, an NRC-sponsored code (current version VARSKIN+ under NUREG/CR-6918, Revision 4) that computes the shallow-dose equivalent from a defined activity, radionuclide, source area, cover or air gap, and exposure time, using ICRP nuclear decay data. The dose equals the calculated shallow-dose-equivalent rate multiplied by the contact time. VARSKIN's default averaging area is 10 cm², matching the regulatory averaging rule.

Which radionuclides pose the greatest skin-dose risk?

High-energy beta emitters deliver the most skin dose per unit contamination. Phosphorus-32 (beta Emax about 1.71 MeV) and yttrium-90 (Emax about 2.28 MeV) are classic high-skin-dose nuclides. Lower-energy beta and positron emitters such as F-18, Lu-177, and I-131 deliver less per unit activity, and technetium-99m — which has no primary beta — contributes comparatively little skin dose. The half-life and the ability to decontaminate also matter.

How quickly does skin contamination need to be addressed?

Immediately. Skin dose accrues for as long as the contamination remains, so the single most effective control is prompt detection and decontamination. Because dose equals rate times time, cutting the contact time from an hour to a few minutes cuts the dose proportionally. Gentle decontamination — lukewarm water and mild soap, working from the outside in, avoiding abrasion — should begin as soon as contamination is confirmed, followed by a resurvey.

Does skin contamination need to be reported or recorded?

Any dose that occurs must be assessed, and shallow-dose equivalent counts toward the 10 CFR 20.1201 limit and the individual's dose of record. A contamination event should trigger a survey, a dose assessment (often with VARSKIN), decontamination, documentation, and a review of what allowed the contamination. Whether a formal report to the NRC or Agreement State is required depends on the magnitude relative to the limits and the reporting thresholds in the regulations.

Key Takeaways

Skin dose is a distinct quantity. It is the shallow-dose equivalent at 7 mg/cm², averaged over 10 cm², and it is driven by short-range beta and low-energy photon emissions the whole-body badge does not see.
The limit is 500 mSv (50 rem) per year to the skin of the whole body or any extremity under 10 CFR 20.1201 — generous relative to the effective-dose limit, but still governing.
Dose is rate times time. For a given contamination, prompt detection and decontamination are the dominant controls; time on the skin is the variable you actually control.
Radionuclide matters. High-energy beta emitters (Y-90, P-32) deliver far more skin dose per unit contamination than low-energy or photon-only emitters (Tc-99m).
VARSKIN is the assessment standard. Assess significant events with VARSKIN (NUREG/CR-6918), recording nuclide, activity, area, cover, and contact time.
Document and prevent. Survey, decontaminate gently, assess, record to the dose of record, and investigate the process gap.

Conclusion

Skin dose from radioactive contamination is a small problem when the program is disciplined and a serious one when it is not — and the difference is almost entirely a matter of detection and response time. Because the dose accrues only while the contamination remains, and because the whole-body dosimeter cannot see it, the controls that work are the mundane ones: survey with the right instrument, decontaminate promptly and gently, assess the shallow-dose equivalent with a VARSKIN-class tool, document it to the dose of record, and fix the workflow gap that let it happen. A facility that treats every skin contamination as a survey-assess-decontaminate-document event keeps its workers well under the limit and its program defensible.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine and research facilities build skin-dose control into their radiation safety programs. Our board-certified medical physicists and health physicists support radiation safety officer programs with contamination-survey design, instrument selection and calibration review, decontamination and spill-response procedures, VARSKIN-based dose assessment, dose-of-record documentation, and radiation safety training for staff who handle unsealed radionuclides.

DRPS serves facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware. To strengthen your contamination-control and skin-dose program, contact our team.

Related Resources

References

U.S. Nuclear Regulatory Commission. 10 CFR 20.1201: Occupational dose limits for adults. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR 20.1003: Definitions (shallow-dose equivalent; 0.007 cm depth). ecfr.gov
U.S. Nuclear Regulatory Commission. Revision of the Skin Dose Limit — averaging over 10 cm². Federal Register; April 5, 2002. federalregister.gov
U.S. Nuclear Regulatory Commission. VARSKIN+ 1.0: A Computer Code for Skin Contamination and Dosimetry Assessments. NUREG/CR-6918, Revision 4. Washington, DC: NRC; 2021. nrc.gov
U.S. Nuclear Regulatory Commission. Regulatory Guide 8.34, Revision 1: Monitoring Criteria and Methods to Calculate Occupational Radiation Doses. 2022. nrc.gov
U.S. Nuclear Regulatory Commission. 10 CFR 20.1501: General (surveys and monitoring). ecfr.gov
International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP. 2007;37(2-4). icrp.org
U.S. Nuclear Regulatory Commission. Health Physics Questions and Answers — skin dose assessment. nrc.gov
National Nuclear Data Center, Brookhaven National Laboratory. NuDat nuclear decay data (beta endpoint energies). nndc.bnl.gov
U.S. Nuclear Regulatory Commission. 10 CFR 20.1906: Procedures for receiving and opening packages. ecfr.gov